Lin Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lin Wang has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Guanhua Du
Beijing Key Laboratory of Innovative Drug Discovery and Polymorphic Druggability Research for Cerebrovascular Diseases, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China
2 shared publications - Jinhua Wang
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China; Key Laboratory of Innovative Drug Discovery and Polymorphic Druggability Research for Cerebrovascular Diseases, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, China
2 shared publications - Ziru Yu
Chinese Academy of Medical Sciences and Peking Union Medical College
2 shared publications - Junke Song
Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
1 shared publication - Shengqian Yang
Beijing Key Laboratory of Drug Target Identification, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, PR China
1 shared publication - Shuyue Ren
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China
1 shared publication
Latest Publications
- 1 October 2018
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1862 (10) , 2281-2292
Metabolic reprogramming in colon cancer reversed by DHTS through regulating PTEN/AKT/HIF1α mediated signal pathway
- 1 October 2018
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1862 (10) , 2281-2292
Metabolic reprogramming in colon cancer reversed by DHTS through regulating PTEN/AKT/HIF1α mediated signal pathway
- 1 March 2017
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 200, 147-155
The natural product bergenin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NF-kappaB activition
- 1 March 2017
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 200, 147-155
The natural product bergenin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NF-kappaB activition